Minimal Change Disease Associated With Durvalumab

por Toda, Masataro G., Fujii, Kentaro, Kato, Ai, Yoshifuji, Ayumi, Komatsu, Motoaki, Amino, Yoshiaki, Kitazono, Satoru, Hashiguchi, Akinori, Ryuzaki, Munekazu
Publicado 2021

Real-World Outcome Analysis of Patients With Stage IV NSCLC Treated With Tyrosine Kinase and Immune Checkpoint Inhibitors

por Ariyasu, Ryo, Kakuto, Sho, Miyadera, Keiki, Akita, Takahiro, Kiritani, Ayu, Tsugitomi, Ryosuke, Amino, Yoshiaki, Uchibori, Ken, Kitazono, Satoru, Yanagitani, Noriko, Nishio, Makoto
Publicado 2023

Lung Adenocarcinoma with Lynch Syndrome and the Response to Nivolumab

por Kawashima, Yosuke, Nishikawa, Shingo, Ninomiya, Hironori, Yoshida, Reiko, Takano, Natsuki, Oguri, Tomoyo, Kitazono, Satoru, Yanagitani, Noriko, Horiike, Atsushi, Ohyanagi, Fumiyoshi, Ishikawa, Yuichi, Nishio, Makoto
Publicado 2019

Implementation of microsatellite instability testing for the assessment of solid tumors in clinical practice

por Nakayama, Izuma, Shinozaki, Eiji, Kawachi, Hiroshi, Sasaki, Takashi, Yunokawa, Mayu, Tomomatsu, Junichi, Yuasa, Takeshi, Kitazono, Satoru, Kobayashi, Kokoro, Hayakawa, Keiko, Ueki, Arisa, Takahashi, Shunji, Yamaguchi, Kensei
Publicado 2022

Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer

por Horinouchi, Hidehito, Yamamoto, Noboru, Fujiwara, Yutaka, Sekine, Ikuo, Nokihara, Hiroshi, Kubota, Kaoru, Kanda, Shintaro, Yagishita, Shigehiro, Wakui, Hiroshi, Kitazono, Satoru, Mizugaki, Hidenori, Tokudome, Takuto, Tamura, Tomohide
Publicado 2015

EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer

por Sonoda, Tomoaki, Nishikawa, Shingo, Sakakibara, Rie, Saiki, Masafumi, Ariyasu, Ryo, Koyama, Junji, Kitazono, Satoru, Yanagitani, Noriko, Horiike, Atsushi, Ohyanagi, Fumiyoshi, Ninomiya, Hironori, Ishikawa, Yuichi, Nishio, Makoto
Publicado 2018

Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms

por Yanagitani, Noriko, Uchibori, Ken, Koike, Sumie, Tsukahara, Mika, Kitazono, Satoru, Yoshizawa, Takahiro, Horiike, Atsushi, Ohyanagi, Fumiyoshi, Tambo, Yuichi, Nishikawa, Shingo, Fujita, Naoya, Katayama, Ryohei, Nishio, Makoto
Publicado 2020

Clinical influence of switching companion diagnostic tests for EGFR‐TKs from Therascreen to Cobas v2

por Uchibori, Ken, Takano, Natsuki, Manabe, Ryo, Tsugitomi, Ryosuke, Ogusu, Shinsuke, Tozuka, Takehiro, Sakamoto, Hiroaki, Yoshida, Hiroshi, Amino, Yoshiaki, Ariyasu, Ryo, Kitazono, Satoru, Yanagitani, Noriko, Nishio, Makoto
Publicado 2021

Characteristics of central nervous system progression in non‐small cell lung cancer treated with crizotinib or alectinib

por Sakamoto, Hiroaki, Yanagitani, Noriko, Manabe, Ryo, Tsugitomi, Ryosuke, Ogusu, Shinsuke, Tozuka, Takehiro, Yoshida, Hiroshi, Amino, Yoshiaki, Ariyasu, Ryo, Uchibori, Ken, Kitazono, Satoru, Tasaka, Sadatomo, Nishio, Makoto
Publicado 2021

Clinical characteristics of patients with KRAS mutation detected by liquid biopsy

por Amino, Yoshiaki, Low, Siew‐Kee, Ninomiya, Hironori, Kiritani, Ayu, Miyadera, Keiki, Kakuto, Sho, Akita, Takahiro, Tsugitomi, Ryosuke, Ariyasu, Ryo, Uchibori, Ken, Kitazono, Satoru, Yanagitani, Noriko, Nishio, Makoto
Publicado 2023

Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients

por Kitazono, Satoru, Sakai, Kazuko, Yanagitani, Noriko, Ariyasu, Ryo, Yoshizawa, Takahiro, Dotsu, Yosuke, Koyama, Junji, Saiki, Masafumi, Sonoda, Tomoaki, Nishikawa, Shingo, Uchibori, Ken, Horiike, Atsushi, Nishio, Kazuto, Nishio, Makoto
Publicado 2019

Feasibility of next‐generation sequencing test for patients with advanced NSCLC in clinical practice

por Ariyasu, Ryo, Uchibori, Ken, Ninomiya, Hironori, Ogusu, Shinsuke, Tsugitomi, Ryosuke, Manabe, Ryo, Sakamaoto, Hiroaki, Tozuka, Takehiro, Yoshida, Hiroshi, Amino, Yoshiaki, Kitazono, Satoru, Yanagitani, Noriko, Takeuchi, Kengo, Nishio, Makoto
Publicado 2020

A phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell...

por Mizugaki, Hidenori, Yamamoto, Noboru, Nokihara, Hiroshi, Fujiwara, Yutaka, Horinouchi, Hidehito, Kanda, Shintaro, Kitazono, Satoru, Yagishita, Shigehiro, Xiong, Hao, Qian, Jane, Hashiba, Hideyuki, Shepherd, Stacie P., Giranda, Vincent, Tamura, Tomohide
Publicado 2015

Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand...

por Tozuka, Takehiro, Kitazono, Satoru, Sakamoto, Hiroaki, Yoshida, Hiroshi, Amino, Yoshiaki, Uematsu, Shinya, Yoshizawa, Takahiro, Hasegawa, Tsukasa, Uchibori, Ken, Yanagitani, Noriko, Horiike, Atsushi, Horai, Takeshi, Seike, Masahiro, Gemma, Akihiko, Nishio, Makoto
Publicado 2020

Poor efficacy of anti‐programmed cell death‐1/ligand 1 monotherapy for non‐small cell lung cancer patients with active brain metastases

por Tozuka, Takehiro, Kitazono, Satoru, Sakamoto, Hiroaki, Yoshida, Hiroshi, Amino, Yoshiaki, Uematsu, Shinya, Yoshizawa, Takahiro, Hasegawa, Tsukasa, Ariyasu, Ryo, Uchibori, Ken, Yanagitani, Noriko, Horai, Takeshi, Seike, Masahiro, Gemma, Akihiko, Nishio, Makoto
Publicado 2020

Monitoring epidermal growth factor receptor C797S mutation in Japanese non–small cell lung cancer patients with serial cell‐free DNA evaluation using digital droplet PCR

por Ariyasu, Ryo, Uchibori, Ken, Sasaki, Takaaki, Tsukahara, Mika, Kiyotani, Kazuma, Yoshida, Ryohei, Ono, Yusuke, Kitazono, Satoru, Ninomiya, Hironori, Ishikawa, Yuichi, Mizukami, Yusuke, Yanagitani, Noriko, Fujita, Naoya, Nishio, Makoto, Katayama, Ryohei
Publicado 2021

Effect of metformin on residual cells after chemotherapy in a human lung adenocarcinoma cell line

por KITAZONO, SATORU, TAKIGUCHI, YUICHI, ASHINUMA, HIRONORI, SAITO-KITAZONO, MIYAKO, KITAMURA, ATSUSHI, CHIBA, TETSUHIRO, SAKAIDA, EMIKO, SEKINE, IKUO, TADA, YUJI, KUROSU, KATSUSHI, SAKAO, SEIICHIRO, TANABE, NOBUHIRO, IWAMA, ATSUSHI, YOKOSUKA, OSAMU, TATSUMI, KOICHIRO
Publicado 2013

Pharmacokinetic and dose‐finding study of osimertinib in patients with impaired renal function and low body weight

por Fujiwara, Yutaka, Makihara, Reiko, Hase, Tetsunari, Hashimoto, Naozumi, Naito, Tomoyuki, Tsubata, Yukari, Okuno, Takae, Takahashi, Toshiaki, Kobayashi, Haruki, Shinno, Yuki, Zenke, Yoshitaka, Ikeda, Takaya, Hosomi, Yukio, Watanabe, Kageaki, Kitazono, Satoru, Sakiyama, Naomi, Makino, Yoshinori, Yamamoto, Noboru
Publicado 2023

Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma

por Okuma, Yusuke, Goto, Yasushi, Ohyanagi, Fumiyoshi, Sunami, Kuniko, Nakahara, Yoshiro, Kitazono, Satoru, Kudo, Keita, Tambo, Yuichi, Kanda, Shintaro, Yanagitani, Noriko, Horiike, Atsushi, Horinouchi, Hidehito, Fujiwara, Yutaka, Nokihara, Hiroshi, Yamamoto, Noboru, Nishio, Makoto, Ohe, Yuichiro, Hosomi, Yukio
Publicado 2020

Rapid genomic profiling of circulating tumor DNA in non-small cell lung cancer using Oncomine Precision Assay with Genexus™ integrated sequencer

por Low, Siew-Kee, Ariyasu, Ryo, Uchibori, Ken, Hayashi, Rie, Chan, Hiu Ting, Chin, Yoon Ming, Akita, Takahiro, Harutani, Yuhei, Kiritani, Ayu, Tsugitomi, Ryosuke, Manabe, Ryo, Ogusu, Shinsuke, Amino, Yoshiaki, Kitazono, Satoru, Yanagitani, Noriko, Nakamura, Yusuke, Nishio, Makoto
Publicado 2022